In this study, insulin-containing nanoparticles were loaded into pellet cores and orally administered to diabetic rats. Polyethylene imine-based nanoparticles, either placebo or loaded with insulin, were incorporated by extrusion and spheronization technology into cores that were subsequently coated with three overlapping layers and a gastroresistant film. The starting and coated systems were evaluated in vitro for their physico-technololgical characteristics, as well as disintegration and release performance. Nanoparticles-loaded cores showed homogeneous particle size distribution and shape. When a superdisintegrant and a soluble diluent were included in the composition enhanced disintegration and release performance were observed. The selected formulations, coated either with enteric or three-layer films, showed gastroresistant and release delayed behavior in vitro, respectively. The most promising formulations were finally tested for their hypoglycemic effect in diabetic rats. Only the nanoformulations loaded into the three-layer pellets were able to induce a significant hypoglycemic activity in diabetic rats. Our results suggest that this efficient activity could be attributed to a retarded release of insulin into the distal intestine, characterized by relatively low proteolytic activity and optimal absorption.

Salvioni, L., Fiandra, L., Del Curto, M., Mazzucchelli, S., Allevi, R., Truffi, M., et al. (2016). Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats. PHARMACOLOGICAL RESEARCH, 110, 122-130 [10.1016/j.phrs.2016.05.016].

Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats

SALVIONI, LUCIA
Primo
;
Fiandra, L;MAZZUCCHELLI, SERENA;SANTINI, BENEDETTA;COLOMBO, MIRIAM
Ultimo
2016

Abstract

In this study, insulin-containing nanoparticles were loaded into pellet cores and orally administered to diabetic rats. Polyethylene imine-based nanoparticles, either placebo or loaded with insulin, were incorporated by extrusion and spheronization technology into cores that were subsequently coated with three overlapping layers and a gastroresistant film. The starting and coated systems were evaluated in vitro for their physico-technololgical characteristics, as well as disintegration and release performance. Nanoparticles-loaded cores showed homogeneous particle size distribution and shape. When a superdisintegrant and a soluble diluent were included in the composition enhanced disintegration and release performance were observed. The selected formulations, coated either with enteric or three-layer films, showed gastroresistant and release delayed behavior in vitro, respectively. The most promising formulations were finally tested for their hypoglycemic effect in diabetic rats. Only the nanoformulations loaded into the three-layer pellets were able to induce a significant hypoglycemic activity in diabetic rats. Our results suggest that this efficient activity could be attributed to a retarded release of insulin into the distal intestine, characterized by relatively low proteolytic activity and optimal absorption.
Articolo in rivista - Articolo scientifico
Insulin release; Multiple-unit formulation; Peptide oral delivery; Polymeric nanoparticles; Type 1 diabetes;
Insulin release; Multiple-unit formulation; Peptide oral delivery; Polymeric nanoparticles; Type 1 diabetes; Pharmacology
English
2016
110
122
130
partially_open
Salvioni, L., Fiandra, L., Del Curto, M., Mazzucchelli, S., Allevi, R., Truffi, M., et al. (2016). Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats. PHARMACOLOGICAL RESEARCH, 110, 122-130 [10.1016/j.phrs.2016.05.016].
File in questo prodotto:
File Dimensione Formato  
Salvioni-2016-Pharmacological Research-VoR.pdf

Solo gestori archivio

Descrizione: Perspective article
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 1.09 MB
Formato Adobe PDF
1.09 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Salvioni-2016-Pharmacological Research-AAM.pdf

accesso aperto

Descrizione: Perspective article
Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Licenza: Creative Commons
Dimensione 1.41 MB
Formato Adobe PDF
1.41 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/138812
Citazioni
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 32
Social impact